An approval letter is a good day and a new set of liabilities. Alongside the authorization come commitments: a post-marketing safety study, a specified analysis in a defined population, a stability programme at a new site, a labelling comparison, a registry with an agreed enrolment target. Each carries a date that the regulator holds, and each must be reported on periodically whether or not progress has been made.
The sponsor owns those commitments. The work almost always sits somewhere else. A contract research organization runs the study, a contract manufacturer executes the stability programme, a specialist vendor builds the registry. Those agreements were negotiated by clinical operations or procurement, often after the commitment was agreed, and the milestone dates in the statement of work do not automatically reconcile with the dates in the approval letter.
The result is a familiar annual exercise: regulatory affairs emails study leads asking where each commitment stands, assembles answers of varying confidence, and files a status report. Nothing is systematically wrong, but nothing is systematically verifiable either. Treating commitments as tracked obligations tied to their delivering contracts closes that gap.
Where commitment tracking breaks
Failures are rarely a matter of a forgotten commitment. They are timing and evidence failures, produced by the distance between the regulatory record and the commercial agreements that discharge it.
- Date divergence, the approval letter sets a submission date, the CRO statement of work sets a database lock date, and nobody reconciles the interval needed between them.
- Ownership ambiguity, a commitment is owned by regulatory affairs, delivered by clinical operations and contracted by procurement, so no single role holds both the deadline and the levers.
- Contract amendment drift, a change order extends a study timeline without anyone testing the new date against the regulatory milestone it was built to meet.
- Evidence scattered, the protocol, the final report, the submission confirmation and the vendor deliverable acceptance sit in four systems, so annual reporting is assembly rather than retrieval.
- Silent sub-tier delivery, the CRO subcontracts a central laboratory or imaging vendor, and flow-down of the commitment-critical timeline is assumed rather than verified.
None of these require a lapse of attention. They follow from a structure where the commitment lives in a regulatory tracking tool and the obligation to perform lives in a contract, with no link between them. The milestone that matters to a regulator and the milestone that triggers a vendor payment are managed by different people against different records.
In the United States, post-marketing requirements are studies and trials a sponsor is required to conduct under statutory authority, with reporting obligations and consequences for failure to meet milestones without adequate justification. Post-marketing commitments are agreed but not required under those authorities. Both are reported on, but their consequences differ, so a register that does not distinguish them will over-escalate some items and under-escalate others.
What a commitment register has to hold
The register is the single place where the regulatory deadline and the contractual deliverable meet. It needs enough structure to answer a status question without a round of emails, and enough linkage to survive a change order.
- Commitment classification. whether the item is a requirement, a commitment, a specific obligation or an agreed paediatric measure, since the category sets both the reporting duty and the escalation threshold.
- Regulator-facing milestone dates. the final protocol, study completion and submission dates exactly as stated in the approval correspondence, held separately from internal plan dates.
- Delivering contract link. the CRO, CDMO or vendor agreement under which the work is performed, linked to the commitment so an amendment to one is visible from the other.
- Named accountable owner. a single person accountable for the milestone, distinct from the study lead, with escalation defined before a date is at risk rather than after.
- Evidence set. the artefacts that demonstrate completion, including the deliverable acceptance record, final report and submission confirmation, attached to the commitment itself.
A five-step roadmap for commitment control
Step 1, Transcribe commitments verbatim
Build the register from the approval correspondence itself, not from a project summary. Capture the exact wording, the classification and each stated date. Paraphrasing is where scope quietly narrows, and a commitment described in shorthand becomes a commitment nobody can test against the original text when a question arises.
Step 2, Map each commitment to its delivering agreement
For every item, identify the contract under which the work will be performed. Where no agreement exists yet, the commitment carries an open procurement dependency, which is itself a tracked risk. Where one exists, link them so the contract record shows which regulatory commitments depend on it and the register shows which contract delivers each item, the same linkage used in quality agreement tracking for sponsors and CDMOs.
Step 3, Reconcile dates and build in lead time
Work backwards from the regulator-facing date through the submission preparation, report finalization and database lock steps to the contractual milestone. Record the required interval explicitly. This is the step that catches statements of work whose final deliverable date leaves no room to prepare a submission.
Step 4, Govern change orders against commitments
Any amendment that moves a delivery date must be tested against the linked commitment before approval. Route change orders through a check that surfaces the dependent regulatory milestone, so a commercially sensible extension is not approved in ignorance of a date held by a regulator.
Step 5, Report from the register, not from inboxes
Annual reporting becomes extraction: status, date, evidence, variance explanation. When the register holds the evidence, the periodic report is assembled from the same records that track the work, which is how obligation management in life sciences is meant to operate, which also means an inspection request can be answered from one place.
Link commitments to the contracts that deliver them
Aavenir Obligationflow tracks regulatory commitments as dated obligations with owners and evidence, linked to the CRO and CDMO agreements behind them.
Why the link to the contract matters most
A commitment register without contract linkage degrades into a list of dates maintained by hand. The link is what gives the register leverage: it makes the dependency visible when a change order is raised, it exposes which vendor deliverable acceptance constitutes evidence of progress, and it lets a sponsor see, before signing, whether the proposed timeline is compatible with an obligation already given to a regulator. It also answers the practical question that arises during inspection readiness, which is not whether the commitment was met but whether the organization can show how and when.
Commitment types and what each needs
The table maps common commitment categories to the delivering agreement and the evidence that demonstrates completion.
| Commitment type | Typical delivering agreement | Key tracked date | Completion evidence |
|---|---|---|---|
| Post-marketing safety study | CRO master service agreement | Final report submission | Report, submission receipt |
| Specified population analysis | CRO or statistical vendor SOW | Database lock | Analysis output, acceptance |
| Registry with enrolment target | Registry vendor agreement | Enrolment milestone | Enrolment report, audit trail |
| Stability programme at new site | CDMO quality and supply agreement | Data availability date | Stability data, batch records |
| Paediatric plan measure | CRO agreement or internal study | Agreed completion date | Study report, deferral record |
Post-approval commitments are the clearest case in life sciences of an obligation created in one system and discharged in another. The regulator holds the date; the contract holds the work. When those two records are not linked, status becomes an annual act of reconstruction and change orders get approved against dates nobody checked. A register built from the approval correspondence verbatim, linked to the delivering agreement, with explicit lead time and a named accountable owner, turns a reporting scramble into retrieval. It also gives the sponsor something more useful than compliance, which is the ability to see a timeline problem while there is still time to act on it.
For related guidance, see The quality leader’s guide to quality agreement management, GxP supplier qualification, contract controls that hold and Quality agreement obligations pharma teams keep missing.
